222 related articles for article (PubMed ID: 929137)
1. [Aldosterone and renin in liver cirrhosis with ascites].
Vetter H; Vetter W; Beckerhoff R; Glänzer K; Furrer J; Hahn C; Kolloch R; Krück F; Kutz K; Siegenthaler W; Witassek F
Schweiz Med Wochenschr; 1977 Dec; 107(48):1755-9. PubMed ID: 929137
[TBL] [Abstract][Full Text] [Related]
2. Studies of renin and aldosterone in cirrhotic patients with ascites.
Rosoff L; Zia P; Reynolds T; Horton R
Gastroenterology; 1975 Sep; 69(3):698-705. PubMed ID: 1158087
[TBL] [Abstract][Full Text] [Related]
3. Components of the renin-angiotensin-aldosterone system in plasma and ascites in hepatic cirrhosis.
Kuiper JJ; Boomsma F; van Buren H; de Man R; Danser AH; van den Meiracker AH
Eur J Clin Invest; 2008 Dec; 38(12):939-44. PubMed ID: 19021719
[TBL] [Abstract][Full Text] [Related]
4. Plasma levels of atrial natriuretic peptide in compensated and decompensated cirrhosis of the liver. Relationship with the renin-aldosterone system.
Colantonio D; Casale R; Pasqualetti P
Panminerva Med; 1989; 31(4):166-70. PubMed ID: 2534427
[TBL] [Abstract][Full Text] [Related]
5. [Cirrhotic ascites and the renin-angiotensin system].
Gonvers JJ; Loup P; Hofstetter JR; Brunner HR
Schweiz Med Wochenschr; 1980 May; 110(22):869-71. PubMed ID: 6996085
[TBL] [Abstract][Full Text] [Related]
6. The renin-angiotensin-aldosterone system in decompensated cirrhosis: its activity in relation to sodium balance.
Sellars L; Shore AC; Mott V; Wilkinson R
Q J Med; 1985 Aug; 56(220):485-96. PubMed ID: 3901077
[TBL] [Abstract][Full Text] [Related]
7. Interrelationship between atrial natriuretic peptide and plasma renin, aldosterone and catecholamines in hepatic cirrhosis: the effect of passive leg rising.
Burghardt W; Müller R; Diehl KL; Wernze H
Z Kardiol; 1988; 77 Suppl 2():104-10. PubMed ID: 2970163
[TBL] [Abstract][Full Text] [Related]
8. [Biological factors influencing response to diuretics in patients with cirrhosis and ascites].
Lenaerts A; Codden T; Henry JP; Van Cauter J; Meunier JC; Ligny G
Gastroenterol Clin Biol; 2001 Mar; 25(3):268-72. PubMed ID: 11395674
[TBL] [Abstract][Full Text] [Related]
9. The renal and hemodynamic effects of the peritoneovenous shunt for intractable hepatic ascites.
Blendis LM; Greig PD; Langer B; Baigrie RS; Ruse J; Taylor BR
Gastroenterology; 1979 Aug; 77(2):250-7. PubMed ID: 447039
[TBL] [Abstract][Full Text] [Related]
10. Renal hemodynamics and the renin-angiotensin system in cirrhosis.
Aliaga L; Zozaya JM; Quiroga J; Richter JA; Prieto J
Rev Esp Fisiol; 1989; 45 Suppl():371-5. PubMed ID: 2701770
[TBL] [Abstract][Full Text] [Related]
11. Renal effects of treatment with diuretics, octreotide or both, in non-azotemic cirrhotic patients with ascites.
Kalambokis G; Economou M; Fotopoulos A; Bokharhii JA; Katsaraki A; Tsianos EV
Nephrol Dial Transplant; 2005 Aug; 20(8):1623-9. PubMed ID: 15886218
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
[TBL] [Abstract][Full Text] [Related]
13. Effect of beta adrenergic blocking drugs on the renin-aldosterone system, sodium excretion, and renal hemodynamics in cirrhosis with ascites.
Wilkinson SP; Bernardi M; Smith IK; Jowett TP; Slater JD; Williams R
Gastroenterology; 1977 Oct; 73(4 Pt 1):659-63. PubMed ID: 19338
[TBL] [Abstract][Full Text] [Related]
14. Nadolol plus spironolactone in the prophylaxis of first variceal bleed in nonascitic cirrhotic patients: A preliminary study.
Abecasis R; Kravetz D; Fassio E; Ameigeiras B; Garcia D; Isla R; Landeira G; Dominguez N; Romero G; Argonz J; Terg R
Hepatology; 2003 Feb; 37(2):359-65. PubMed ID: 12540786
[TBL] [Abstract][Full Text] [Related]
15. Effects of clonidine on diuretic response in ascitic patients with cirrhosis and activation of sympathetic nervous system.
Lenaerts A; Codden T; Meunier JC; Henry JP; Ligny G
Hepatology; 2006 Oct; 44(4):844-9. PubMed ID: 17006921
[TBL] [Abstract][Full Text] [Related]
16. [Prognostic value of the renin-angiotensin system in response to salt restriction and prognosis of alcoholic ascitic cirrhosis].
Genoud E; Gonvers JJ; Schaller MD; Essinger A; Haller E; Brunner HR
Schweiz Med Wochenschr; 1986 Apr; 116(15):463-9. PubMed ID: 3518053
[TBL] [Abstract][Full Text] [Related]
17. Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites. Relationship between the diuretic response and the activity of the renin-aldosterone system.
Pérez-Ayuso RM; Arroyo V; Planas R; Gaya J; Bory F; Rimola A; Rivera F; Rodés J
Gastroenterology; 1983 May; 84(5 Pt 1):961-8. PubMed ID: 6339312
[TBL] [Abstract][Full Text] [Related]
18. Comparative pharmacodynamics of furosemide and muzolimine in cirrhosis. Study on renal sodium and potassium handling and renin-aldosterone axis.
Bernardi M; De Palma R; Trevisani F; Santini C; Servadei D; Gasbarrini G
Z Kardiol; 1985; 74 Suppl 2():129-34. PubMed ID: 3890391
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-6, nitric oxide, and the clinical and hemodynamic alterations of patients with liver cirrhosis.
Genesca J; Gonzalez A; Segura R; Catalan R; Marti R; Varela E; Cadelina G; Martinez M; Lopez-Talavera JC; Esteban R; Groszmann RJ; Guardia J
Am J Gastroenterol; 1999 Jan; 94(1):169-77. PubMed ID: 9934750
[TBL] [Abstract][Full Text] [Related]
20. Reduction in hepatic venous pressure gradient as a consequence of volume contraction due to chronic administration of spironolactone in patients with cirrhosis and no ascites.
Okumura H; Aramaki T; Katsuta Y; Satomura K; Akaike M; Sekiyama T; Terada H; Ohsuga M; Komeichi H; Tsutsui H
Am J Gastroenterol; 1991 Jan; 86(1):46-52. PubMed ID: 1986554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
